Is Continuing Anticoagulation or Antiplatelet Therapy Safe Prior to Kidney Transplantation?
Open Access
- 11 August 2021
- journal article
- research article
- Published by International Scientific Information, Inc. in Annals of Transplantation
- Vol. 26, e931648-1-e931648-4
- https://doi.org/10.12659/aot.931648
Abstract
Is Continuing Anticoagulation or Antiplatelet Therapy Safe Prior to Kidney Transplantation? - Article abstract #931648Keywords
This publication has 11 references indexed in Scilit:
- Perioperative Bridging Anticoagulation in Patients with Atrial FibrillationThe New England Journal of Medicine, 2015
- Kidney transplantation without interruption of warfarinClinical Transplantation, 2015
- Use and Outcomes Associated With Bridging During Anticoagulation Interruptions in Patients With Atrial FibrillationJournal of the American College of Cardiology, 2015
- 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial FibrillationJournal of Invasive Cardiology, 2014
- CorrectionJournal of Invasive Cardiology, 2014
- Does Antiplatelet Therapy Affect Outcomes of Patients Receiving Abdominal Laparoscopic Surgery? Lessons from more than 1,000 Laparoscopic Operations in a Single Tertiary Referral HospitalJournal of the American College of Surgeons, 2013
- Bridging AnticoagulationJournal of the American College of Cardiology, 2012
- Non-cardiac surgery in patients with coronary stents: the RECO studyPublished by BMJ ,2011
- Bridging therapy and oral anticoagulation: current and future prospectsCurrent Opinion in Hematology, 2010
- The impact of peritransplant warfarin use on renal transplant outcome.2010